Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.58 |
| ▸ | KCNK10 | P57789 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | ERO1A | Q96HE7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | PYGL | P06737 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2031092 | 0.93 | KCNK2 (0.64) | HTTSMN1; SMN2KMT2AHPGDKCNK2 | |
| SCHEMBL13802483 | 0.90 | WDR5 (0.60) | HTTSMN1; SMN2KMT2AHPGDKCNK2 | |
| SCHEMBL13802485 | 0.87 | SERPINE1 (0.59) | HTTSMN1; SMN2KMT2AHPGDKCNK2 | |
| SCHEMBL14075220 | 0.84 | MEN1 (0.71) | HTTSMN1; SMN2KMT2AKCNK2KCNK10 | |
| SCHEMBL2024935 | 0.84 | MEN1 (0.71) | KMT2AERO1AMEN1MAPTALDH1A1 | |
| SCHEMBL2244157 | 0.83 | HTT (0.76) | HTTSMN1; SMN2KMT2AHPGDCYP3A4 | |
| SCHEMBL4976826 | 0.81 | HTT (0.61) | HTTSMN1; SMN2KMT2AHPGDERO1A | |
| SCHEMBL7787033 | 0.81 | KMT2A (0.72) | KMT2AKCNK2KCNK10ERO1AMEN1 | |
| SCHEMBL5156571 | 0.80 | SMN1; SMN2 (0.67) | HTTSMN1; SMN2KMT2ACYP3A4MAPT | |
| SCHEMBL11235113 | 0.79 | ALDH1A1 (0.58) | SMN1; SMN2KMT2AMEN1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090155903-A1 | PHARMACEUTICAL COMPOSITION AND METHOD | MYRIAD GENETICS, INCORPORATED (US) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155903-A1 | PHARMACEUTICAL COMPOSITION AND METHOD | APP, PSEN2, PSEN1 | HTT 5/4885SMN1; SMN2 37/4885KMT2A 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.